IBR vs RAP for 2026 Medical School Graduates: Which Plan Wins

You graduated in May 2026 with $247,000 in federal student loans — the median debt load for new MD graduates according to AAMC's 2024 data. Your intern salary is $63,000. You have exactly one question: which repayment plan do you sign up for?

For the first time in years, the answer isn't complicated by four competing income-driven options. SAVE is dead — vacated by the 8th Circuit on March 10, 2026. PAYE closed to new enrollees on July 1, 2026. You're left with two real choices: Income-Based Repayment (IBR) and the brand-new Repayment Assistance Plan (RAP). The problem is that almost nobody in your residency program understands the difference, and picking wrong could cost you tens of thousands of dollars over the next decade.

This article breaks down exactly how IBR vs RAP stacks up for 2026 medical school graduates — payment amounts, forgiveness timelines, PSLF eligibility, and the specific scenarios where each plan wins.

Why IBR vs RAP Is the Only Question That Matters for 2026 Medical Graduates

Before 2026, residents juggled four income-driven repayment options: IBR, PAYE, REPAYE, and SAVE. That landscape collapsed overnight into two:

• IBR — the long-standing plan, available to any borrower with a partial financial hardship, capping payments at 10% of discretionary income for new borrowers (those who took out their first federal loan after July 1, 2014). Forgiveness happens at 20 years.
• RAP (Repayment Assistance Plan) — brand new, applies only to loans first disbursed on or after July 1, 2026. This is the critical eligibility gate most residents miss.

Here's where it gets important: if your loans were disbursed before July 1, 2026 — which is true for virtually every student who started medical school before fall 2022 — RAP is not available to you. IBR is your only income-driven option. Done.

If you're a 2026 graduate who received loans disbursed on or after July 1, 2026 (a small subset of bridge or supplemental disbursements, or incoming MS1s starting July 2026), then RAP becomes relevant. Most M4s reading this are IBR-only.

Check your disbursement dates in studentaid.gov first. Seriously. This distinction determines everything.

How IBR Payments Work During Residency (With Real Numbers)

Under IBR for new borrowers post-July 2014, your monthly payment is 10% of discretionary income — your adjusted gross income minus 225% of the federal poverty guideline for your household size.

Here's what that actually looks like for a single PGY-1 in 2026:

• Gross income: $63,000
• 225% of federal poverty line (single person, 2026 estimate): ~$33,750
• Discretionary income: $63,000 − $33,750 = $29,250
• 10% of that: $2,925/year → $244/month

On a $247,000 balance at 7.05% interest (the 2024–2025 grad PLUS rate was 9.08%, but direct unsubsidized for grad students was 8.08%; let's use 7.05% for illustrative purposes), you're accruing roughly $1,454/month in interest. Your $244 payment doesn't scratch the surface. The balance grows—and that's actually the whole point if you're chasing PSLF.

Across a typical 3-year internal medicine residency, or a longer surgical fellowship, you might spend 4–7 years in training. At $244–$350/month the entire time, you accumulate qualifying PSLF payments while keeping your cash flow steady. For physicians targeting PSLF, IBR during residency is the obvious move.

For a deeper breakdown of how loan balances evolve by specialty, see medical school debt by specialty.

How RAP Works — And Who It Actually Applies To

RAP replaces SAVE as the new income-driven option for loans disbursed July 1, 2026 and later. The structure differs meaningfully from IBR:

Payment calculation: RAP uses a sliding scale based on income, starting lower than IBR at very low incomes but converging or exceeding IBR payments at higher income levels. Early Department of Education guidance suggests payments will range from approximately 5% to 10% of discretionary income depending on income bracket.

Forgiveness timeline: 20 years for undergraduate borrowers, 25 years for graduate borrowers — longer than new-borrower IBR's 20-year term.

PSLF eligibility: Yes, RAP payments count toward PSLF. The 2026 regulatory framework confirms this.

Interest subsidy: RAP includes an interest coverage provision similar to what SAVE had — unpaid interest above your payment doesn't capitalize as long as you stay enrolled. This beats IBR, where interest does capitalize in certain circumstances.

The catch: Your loans must be disbursed after July 1, 2026. If not? You can't enroll in RAP.

IBR vs RAP Side-by-Side: The Key Differences

For most 2026 MD graduates, this table tells the story: you're on IBR. That's not a consolation prize. IBR is proven, battle-tested in court, and has generated tens of thousands of PSLF approvals.

The PSLF Lens: IBR Still Wins for Residents at Academic Centers

Train at a nonprofit academic medical center or public hospital? That describes most of the U.S. residency pipeline. IBR becomes a powerhouse.

Every residency month on IBR with an eligible employer counts as a qualifying PSLF payment. A 5-year surgical resident who starts IBR on July 1, 2026 has 60 qualifying payments locked in before their first day as an attending. That's halfway to forgiveness before you even sign your first employment contract.

Zoom out to a primary care lens: a family medicine physician with $247,000 in loans who spends 10 years at a nonprofit hospital and qualifies for PSLF walks away from that balance entirely — tax-free. The PSLF vs aggressive payoff comparison shows just how enormous this gap becomes over a 15-year horizon.

Unsure whether your program qualifies for PSLF? The PSLF employer eligibility changes 2026 article covers the updated criteria.

When RAP Would Win (For the Minority Who Qualify)

For incoming MS1s starting in fall 2026 with first disbursements on or after July 1, 2026, RAP edges ahead in a few specific ways:

Interest doesn't snowball the same way. Under IBR, a resident making $244/month while accruing $1,454/month in interest doesn't trigger immediate capitalization — but RAP's explicit subsidy provision is more protective. Over a 5-year residency, the difference in your ending balance could be $20,000–$40,000.

Lower payments at very low incomes. RAP's sliding scale may produce payments $30–$80/month lower than IBR when you're earning resident salary, which matters when rent is $3,500/month in San Francisco or New York.

The longer forgiveness window doesn't hurt PSLF pursuers. If you're hunting PSLF, you get forgiveness at 120 payments regardless—the 25-year timeline only kicks in if you bail on PSLF-eligible employment. That's worth planning around.

The catch: if you don't achieve PSLF and stick with RAP to term, you're waiting five extra years compared to IBR. For high earners in private practice later—think orthopedic surgery, dermatology, and radiology—that's meaningful money. Model it carefully.

Use the MedDebt quiz to get a specialty-specific recommendation based on your loan balance and career trajectory.

The Refinancing Question: When Neither Plan Is Right

A subset of 2026 graduates should ignore both plans. If you're certain you won't pursue PSLF, plan to pay off loans aggressively within 5–7 years, and are heading into a high-income specialty, income-driven repayment is the wrong tool.

A neurosurgery attending earning $650,000 with $300,000 in loans has no business staying federal. The income-driven payment would be enormous, and the forgiveness timeline is irrelevant—they'll be debt-free in 3 years with aggressive payoff. Refinancing to a 5-year private loan at 5.5%–6.5% saves roughly $80,000–$120,000 in interest compared to running out the federal loan rate.

If this sounds like you, see PSLF vs refinancing for attending physicians and check current refinancing rates at /refinance.

The decision tree is straightforward:

• Nonprofit employer likely → Stay federal, use IBR, pursue PSLF
• Private practice certain → Model aggressive payoff, consider refinancing as attending
• Unsure → Stay federal through residency, reassess at the PGY transition

Frequently Asked Questions: IBR vs RAP for 2026 Medical Graduates

Can 2026 medical graduates enroll in RAP? Only if they have loans first disbursed on or after July 1, 2026. Most M4s who graduated in May or June 2026 took their last disbursements in 2025 or early 2026, making them ineligible for RAP. Their income-driven default is IBR.

Is IBR or RAP better for PSLF? Both generate qualifying PSLF payments. For borrowers eligible for both, RAP's interest subsidy means a lower balance if PSLF falls through, but payment counts toward the 120 qualifying payments work identically under either plan. Eligibility—not plan preference—is the deciding factor.

What happened to SAVE and PAYE in 2026? SAVE was vacated by the 8th Circuit Court of Appeals on March 10, 2026. PAYE closed to new enrollees on July 1, 2026, following the Higher Education Act regulatory changes. New graduates can't enroll in either plan anymore.

What is the IBR payment for a typical PGY-1 resident? For a single resident earning approximately $63,000 with the standard deductions, IBR payments typically fall between $220–$270/month in 2026. The exact figure depends on household size, filing status, and pretax deductions like 403(b) contributions.

Should residents on IBR worry about interest accrual? Yes, but not the way most residents panic about it. Your balance will grow during residency—by $30,000–$60,000 or more depending on your starting balance and training length. That's expected and completely acceptable if you're pursuing PSLF, because the entire remaining balance is forgiven tax-free at 120 payments. If you're not pursuing PSLF? That accruing interest is a real cost that belongs in your repayment strategy. See IBR vs standard repayment for doctors for a full comparison.

Run Your Own Numbers

Every physician's debt situation differs. Use the MedDebt Calculator to model your exact repayment strategy—PSLF vs. aggressive payoff vs. refinancing—with your actual loan balance, specialty, and income.

It's free, takes 2 minutes, and shows you net worth projections by year.

This article is for informational purposes only and does not constitute financial, legal, or tax advice. Every borrower's situation is unique — consult a certified student loan advisor or fee-only financial planner before making repayment decisions.

Disclosure: This article is for informational purposes only and does not constitute financial, legal, or tax advice. Loan program details change — always verify current rules on studentaid.gov. MedDebt may earn a referral commission if you refinance through links on this site.